SCHEMBL27244875

SCHEMBL27244875

CN(C(=O)[C@H](CC1CC1)NC(=O)C(F)(F)F)C(CC1CC1)C(=O)N1C[C@@]2(C[C@H]1C(N)=O)Oc1cc(F)cc(C#N)c1NC2=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27244880 1.00 — —
SCHEMBL27245222 0.90 — —
SCHEMBL27245217 0.90 — —
SCHEMBL30890542 0.90 — —
SCHEMBL30890479 0.87 — —
SCHEMBL27245128 0.85 — —
SCHEMBL27245188 0.85 — —
SCHEMBL27245132 0.85 — —
SCHEMBL27245182 0.85 — —
SCHEMBL27244837 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
US-20240199647-A1 ANTI-VIRAL COMPOUNDS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2024-06-20 — — US disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback